Raymond James & Associates’s DocGo DCGO Stock Holding History
Bought
Maintained
Sold
Other funds holding DCGO
DM
DMKJ
PAIM
SST
PAWC
Raymond James & Associates's DCGO Position: Q3 2024 in Review
Raymond James & Associates increased its DocGo (DCGO) stake by 29% in Q3 2024, buying an estimated $118K and bringing the position to 155,892 shares worth $518K. The position accounts for ﹤0.01% of the portfolio, ranked #3092.
Raymond James & Associates first reported a position in DCGO in Q3 2023 and has held it in 5 quarters since. The position peaked at $1M in Q4 2023. 126 funds tracked by Wall St. Rank hold DCGO as of Q3 2024.
- Raymond James & Associates held 155,892 shares of DocGo worth $518K as of Q3 2024.
- Raymond James & Associates bought 34,579 DocGo shares in Q3 2024, an estimated $118K.
- DocGo made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3092 holding.
- Raymond James & Associates first reported a position in DocGo in Q3 2023 and has held it in 5 quarters since.
- Raymond James & Associates's DocGo position peaked at $1M in Q4 2023.
- 126 funds tracked by Wall St. Rank held DocGo as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.